Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

The Case Against Arthur Sulzberger at The New York Times

By Jonathan Berr, InvestorPlace Contributor
His record as chairman since 1997 has been terrible for shareholders. NYT needs new blood as a leader , someone like Ford's Alan Mulally.

Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?

By Barry Cohen, Health Care Writer
CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns.

Blame Bargains for Best Buy’s Demise

By Jon Markman, Editor, Trader's Advantage and CounterPoint Options
Best Buy's problem isn't unique among retailers -- businesses need sales to bring in price-conscious consumers, but their revenues are getting killed.

Oracle Decks Techs — Wednesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
The software giant's first earnings miss in a decade didn't go over well.

Ariad Pharmaceuticals Still Might Have Upside

By Barry Cohen, Health Care Writer
Ariad Pharmaceuticals is up 120% in the past 12 months, mostly fueled on optimism over its trial leukemia treatment. But some analysts think the ceiling is higher.

Gold, Silver Lower as Banks Flock to Borrow ECB Money

By Andrew Burger, InvestorPlace Contributor
Eldorado Gold, Pan American Silver were among a few gainers going against the grain of downward-moving metal prices, miners Wednesday morning.

Oracle Sounds Another Warning Bell for Tech Sector

By Tom Taulli, InvestorPlace Contributor
The stock took a big hit after missing earnings estimates, causing investors to grow more wary of the tech sector.

ConAgra Rolls as Market Rallies — Tuesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
A pre-Christmas surge on Wall Street lifted many other stocks as well.

The Best and Worst Dow Stock of the Year

By Jeff Reeves
A fast-food giant is on top (up 29%), and a banking giant is on the bottom (down 61%). Get their names and see results for all 30 Dow stocks.

Where AT&T Stands After the T-Mobile Split

By Susan J. Aluise, Aviation, Auto & Transportation Writer
We can't say we didn't see it coming. Despite its desperate attempt to hitch up with T-Mobile, AT&T finally called the whole thing off. What happens next?

Gold Back Above $1,600 on Positive Housing, Euro Zone News

By Andrew Burger, InvestorPlace Contributor
Gold and silver were headed higher Tuesday morning. Miners were surging as well, with Coeur d'Alene Mines and Hecla Mining making aggressive moves.

Buffett Got Burned on Bank of America, and There’s No Bottom in Sight

By Jeff Reeves
Bank of America plummeted below the $5 mark on Monday, but you're not going to hear many people calling it a value stock -- and rightfully so.

Investors Need to Dig Into the Bakken Shale

By Aaron Levitt, InvestorPlace Contributor
The huge oil deposits in North Dakota and Montana could be portfolio-changing investments for those who bet early on the right players.

Bank of America Falls Below $5 — Monday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
BofA's latest slide continues, leading big banks like Citi, JPMorgan, Goldman and Wells Fargo lower. Also, AT&T announces it will end its bid for T-Mobile USA.

Gold Flat, Silver Sliding in Monday Trading

By Andrew Burger, InvestorPlace Contributor
Precious metal trusts, miners were heading lower in a broad range during Monday morning trading. Also, Eldorado Gold announces deal to buy European Gold Fields.

Amgen CEO Says ‘I’m Leaving.’ Investors Say ‘Good Riddance’

By Barry Cohen, Health Care Writer
After a decade as CEO, the oft-maligned Kevin Sharer will step down. That's giving shareholders holiday cheer as they bid the stock up on the news.

RIMM Completes a Week of Gloomy Outlooks — Friday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
Research In Motion joined Intel, Best Buy and First Solar in forecasting leaner times ahead. Here's a look at RIM, as well as other big news from this week.

Researcher: J&J/Pharmacyclics Drug Could Be a Game-Changer

By Barry Cohen, Health Care Writer
The experimental cancer drug Johnson & Johnson bought last week is receiving high praise, and could be "paradigm-shifting."

Despite Record Orders, Boeing’s McNerney Could Be Ejected

By Susan J. Aluise, Aviation, Auto & Transportation Writer
James McNerney's uneven tenure could be over soon. Would Ford's Alan Mulally move in? Plenty of folks are rooting for the former Boeing exec's return.
Load More Articles